Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Wells Fargo & Company

Start price
€220.00
07.03.24 / 50%
Target price
€298.84
07.03.25
Performance (%)
9.73%
Price
€241.40
19:28
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan shows slight gains of 9.73%. This prediction currently runs until 07.03.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
United Therapeutics 0.274% 0.274%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by Wells_Fargo___Compan for this prediction

In the thread United Therapeutics diskutieren
Prediction Buy
Perf. (%) 9.73%
Target price 298.838
Change
Ends at 07.03.25

United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $309.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat

Stopped prediction by Wells_Fargo___Compan for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€224.60
08.12.23
€287.40
08.12.24
-2.14%
19:28